Marc López-Cano
Affiliations: | 2015-2020 | Department of Pathology and Experimental Therapeutics | Universitat de Barcelona, Barcelona, Cataluña, Spain |
Google:
"Marc López-Cano"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Taura J, López-Cano M, Fernández-Dueñas V, et al. (2023) Visualizing G Protein-Coupled Receptor-Receptor Interactions in Brain Using Proximity Ligation In Situ Assay. Current Protocols. 3: e794 |
| Romero-Fernandez W, Taura JJ, Crans RAJ, et al. (2022) The mGlu Receptor Protomer-Mediated Dopamine D Receptor Trans-Inhibition Is Dependent on the Adenosine A Receptor Protomer: Implications for Parkinson's Disease. Molecular Neurobiology |
| Hüll K, Fernández-Dueñas V, Schönberger M, et al. (2021) Optical Control of Adenosine-Mediated Pain Modulation. Bioconjugate Chemistry |
| López-Cano M, Font J, Aso E, et al. (2021) Remote local photoactivation of morphine produces analgesia without opioid-related adverse effects. British Journal of Pharmacology |
| López-Cano M, Filgaira I, Nolen EG, et al. (2021) Optical control of adenosine A receptor function in psoriasis. Pharmacological Research. 105731 |
| Valle-León M, Callado LF, Aso E, et al. (2020) Decreased striatal adenosine A-dopamine D receptor heteromerization in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology |
| López-Cano M, Fernández-Dueñas V, Ciruela F. (2019) Proximity Ligation Assay Image Analysis Protocol: Addressing Receptor-Receptor Interactions. Methods in Molecular Biology (Clifton, N.J.). 2040: 41-50 |
| López-Cano M, Font J, Llebaria A, et al. (2019) Optical Modulation of Metabotropic Glutamate Receptor Type 5 In Vivo Using a Photoactive Drug. Methods in Molecular Biology (Clifton, N.J.). 1947: 351-359 |
| Aso E, Fernández-Dueñas V, López-Cano M, et al. (2019) Adenosine A-Cannabinoid CB Receptor Heteromers in the Hippocampus: Cannabidiol Blunts Δ-Tetrahydrocannabinol-Induced Cognitive Impairment. Molecular Neurobiology |
| Núñez F, Taura J, Camacho J, et al. (2018) PBF509, an Adenosine A Receptor Antagonist With Efficacy in Rodent Models of Movement Disorders. Frontiers in Pharmacology. 9: 1200 |